Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA/NORD Partnership Will Further Increase Patient Involvement In Drug Development

28 Feb 2018

• By Derrick Gingery

Two businessmen shaking hands during a meeting in the office, success, dealing, greeting & business partner concepts - soft light.

Related Content

From Listening To Advising: The Maturation Of US FDA's Patient-Focused Drug Development Program

09 Jan 2018

Drug Pricing Concerns May Hinder Rare Disease Lobbying Effort

28 Feb 2018

US FDA's Patient Affairs Office Is An Office … In Spirit

17 Nov 2017

FDA Web Portal Eases Pre-ANDA Meeting Request Process

10 Oct 2017

Keytruda's New Tissue-Agnostic Indication Could Prompt Orphan Policy Changes

17 Oct 2017

FDA's Orphan Designation Backlog Plan Focuses On Efficiency, Not Staff

29 Jun 2017

FDA Ends Regularly Scheduled Patient-Focused Drug Development Meetings

29 Sep 2017

Additional Topics

United States Rare Diseases Regulation FDA BioPharmaceutical

More from Rare Diseases

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.